Cargando…

Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

OBJECTIVES: To prospectively investigate changes in M.D. Anderson Dysphagia Inventory (MDADI) scores in patients affected by naso- and oropharynx cancer after definitive radiochemotherapy (ChemoRT) using swallowing organs at risk (SWOARs)-sparing IMRT. METHODS: MDADI questionnaires were collected at...

Descripción completa

Detalles Bibliográficos
Autores principales: Ursino, Stefano, Calistri, Elisa, De Felice, Francesca, Bonomo, Pierluigi, Desideri, Isacco, Franco, Pierfrancesco, Arcadipane, Francesca, Colosimo, Caterina, Mazzola, Rosario, Maddalo, Marta, Gonnelli, Alessandra, Malfatti, Giulia, Morganti, Riccardo, Musio, Daniela, Paiar, Fabiola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118191/
https://www.ncbi.nlm.nih.gov/pubmed/35587295
http://dx.doi.org/10.1007/s00455-022-10434-4
_version_ 1784710461526114304
author Ursino, Stefano
Calistri, Elisa
De Felice, Francesca
Bonomo, Pierluigi
Desideri, Isacco
Franco, Pierfrancesco
Arcadipane, Francesca
Colosimo, Caterina
Mazzola, Rosario
Maddalo, Marta
Gonnelli, Alessandra
Malfatti, Giulia
Morganti, Riccardo
Musio, Daniela
Paiar, Fabiola
author_facet Ursino, Stefano
Calistri, Elisa
De Felice, Francesca
Bonomo, Pierluigi
Desideri, Isacco
Franco, Pierfrancesco
Arcadipane, Francesca
Colosimo, Caterina
Mazzola, Rosario
Maddalo, Marta
Gonnelli, Alessandra
Malfatti, Giulia
Morganti, Riccardo
Musio, Daniela
Paiar, Fabiola
author_sort Ursino, Stefano
collection PubMed
description OBJECTIVES: To prospectively investigate changes in M.D. Anderson Dysphagia Inventory (MDADI) scores in patients affected by naso- and oropharynx cancer after definitive radiochemotherapy (ChemoRT) using swallowing organs at risk (SWOARs)-sparing IMRT. METHODS: MDADI questionnaires were collected at baseline and at 6 and 12 months after treatment. MDADI scores were categorized as follows: ≥ 80 “optimal,” 80–60 “adequate,” < 60 “poor” deglutition-related quality of life (QoL) group, and dichotomized as “optimal” vs “adequate/poor” for the analysis. A mean MDADI composite (MDADI-C) change of 10 points was considered as minimal clinically important difference (MCID). RESULTS: Sixty-three patients were enrolled of which 47 were considered for the analysis. At baseline, 26 (55%) were “optimal” and 21 (45%) were “adequate/poor.” The mean baseline MDADI-C score was 93.6 dropping to 81 at 6 months (p = 0.013) and slightly rising to 85.5 at 12 months (p = 0.321) for the “optimal” group. Indeed, the mean baseline MDADI-C score was 64.3 rising to 77.5 at 6 months (p = 0.006) and stabilizing at 76 at 12 months (p = 0.999) for the “adequate/poor” group. A statistically significant but not clinically relevant worsening of the MDADI-C score was reported for the “optimal” group, whereas both a statistically significant and clinically meaningful improvement of the MDADI-C score were reported for the “adequate/poor” group from before to post-treatment. CONCLUSION: Our results suggest a doubly clinical benefit of dose optimization to SWOARs to minimize the RT sequalae in patients with a baseline “optimal” deglutition-related QoL and to recover from cancer dysphagia in those with a baseline “adequate/poor” deglutition-related QoL. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00455-022-10434-4.
format Online
Article
Text
id pubmed-9118191
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-91181912022-05-19 Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) Ursino, Stefano Calistri, Elisa De Felice, Francesca Bonomo, Pierluigi Desideri, Isacco Franco, Pierfrancesco Arcadipane, Francesca Colosimo, Caterina Mazzola, Rosario Maddalo, Marta Gonnelli, Alessandra Malfatti, Giulia Morganti, Riccardo Musio, Daniela Paiar, Fabiola Dysphagia Original Article OBJECTIVES: To prospectively investigate changes in M.D. Anderson Dysphagia Inventory (MDADI) scores in patients affected by naso- and oropharynx cancer after definitive radiochemotherapy (ChemoRT) using swallowing organs at risk (SWOARs)-sparing IMRT. METHODS: MDADI questionnaires were collected at baseline and at 6 and 12 months after treatment. MDADI scores were categorized as follows: ≥ 80 “optimal,” 80–60 “adequate,” < 60 “poor” deglutition-related quality of life (QoL) group, and dichotomized as “optimal” vs “adequate/poor” for the analysis. A mean MDADI composite (MDADI-C) change of 10 points was considered as minimal clinically important difference (MCID). RESULTS: Sixty-three patients were enrolled of which 47 were considered for the analysis. At baseline, 26 (55%) were “optimal” and 21 (45%) were “adequate/poor.” The mean baseline MDADI-C score was 93.6 dropping to 81 at 6 months (p = 0.013) and slightly rising to 85.5 at 12 months (p = 0.321) for the “optimal” group. Indeed, the mean baseline MDADI-C score was 64.3 rising to 77.5 at 6 months (p = 0.006) and stabilizing at 76 at 12 months (p = 0.999) for the “adequate/poor” group. A statistically significant but not clinically relevant worsening of the MDADI-C score was reported for the “optimal” group, whereas both a statistically significant and clinically meaningful improvement of the MDADI-C score were reported for the “adequate/poor” group from before to post-treatment. CONCLUSION: Our results suggest a doubly clinical benefit of dose optimization to SWOARs to minimize the RT sequalae in patients with a baseline “optimal” deglutition-related QoL and to recover from cancer dysphagia in those with a baseline “adequate/poor” deglutition-related QoL. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00455-022-10434-4. Springer US 2022-05-19 2023 /pmc/articles/PMC9118191/ /pubmed/35587295 http://dx.doi.org/10.1007/s00455-022-10434-4 Text en © The Author(s) 2022, corrected publication 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Ursino, Stefano
Calistri, Elisa
De Felice, Francesca
Bonomo, Pierluigi
Desideri, Isacco
Franco, Pierfrancesco
Arcadipane, Francesca
Colosimo, Caterina
Mazzola, Rosario
Maddalo, Marta
Gonnelli, Alessandra
Malfatti, Giulia
Morganti, Riccardo
Musio, Daniela
Paiar, Fabiola
Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
title Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
title_full Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
title_fullStr Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
title_full_unstemmed Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
title_short Patient-Reported Outcomes After Swallowing (SWOARs)-Sparing IMRT in Head and Neck Cancers: Primary Results from a Prospective Study Endorsed by the Head and Neck Study Group (HNSG) of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
title_sort patient-reported outcomes after swallowing (swoars)-sparing imrt in head and neck cancers: primary results from a prospective study endorsed by the head and neck study group (hnsg) of the italian association of radiotherapy and clinical oncology (airo)
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9118191/
https://www.ncbi.nlm.nih.gov/pubmed/35587295
http://dx.doi.org/10.1007/s00455-022-10434-4
work_keys_str_mv AT ursinostefano patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT calistrielisa patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT defelicefrancesca patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT bonomopierluigi patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT desideriisacco patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT francopierfrancesco patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT arcadipanefrancesca patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT colosimocaterina patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT mazzolarosario patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT maddalomarta patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT gonnellialessandra patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT malfattigiulia patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT morgantiriccardo patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT musiodaniela patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo
AT paiarfabiola patientreportedoutcomesafterswallowingswoarssparingimrtinheadandneckcancersprimaryresultsfromaprospectivestudyendorsedbytheheadandneckstudygrouphnsgoftheitalianassociationofradiotherapyandclinicaloncologyairo